Comparison between Senores Pharmaceuticals IPO and Unimech Aerospace IPO.
Senores Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Unimech Aerospace IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Senores Pharmaceuticals IPO is up to ₹582.11 Cr whereas the issue size of the Unimech Aerospace IPO is up to ₹500.00 Cr. The final issue price of Senores Pharmaceuticals IPO is ₹391.00 per share and of Unimech Aerospace IPO is ₹785.00 per share.
| Senores Pharmaceuticals IPO | Unimech Aerospace IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹5 per share |
| Issue Price (Lower) | ₹372.00 per share | ₹745.00 per share |
| Issue Price (Upper) | ₹391.00 per share | ₹785.00 per share |
| Issue Price (Final) | ₹391.00 per share | ₹785.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 38 shares | 19 shares |
| Fresh Issue Size | 1,27,87,723 shares | 31,84,713 shares |
| Fresh Issue Size (Amount) | up to ₹500.00 Cr | up to ₹250.00 Cr |
| OFS Issue Size | 21,00,000 shares | 31,84,713 shares |
| OFS Issue Size (Amount) | up to ₹82.11 Cr | up to ₹250.00 Cr |
| Issue Size Total | 1,48,87,723 shares | 63,69,426 shares |
| Issue Size Total (Amount) | up to ₹582.11 Cr | up to ₹500.00 Cr |
Senores Pharmaceuticals IPO opens on Dec 20, 2024, while Unimech Aerospace IPO opens on Dec 23, 2024. The closing date of Senores Pharmaceuticals IPO and Unimech Aerospace IPO is Dec 24, 2024, and Dec 26, 2024, respectively.
| Senores Pharmaceuticals IPO | Unimech Aerospace IPO | |
|---|---|---|
| Anchor Bid Date | Dec 19, 2024 | Dec 20, 2024 |
| Issue Open | Dec 20, 2024 | Dec 23, 2024 |
| Issue Close | Dec 24, 2024 | Dec 26, 2024 |
| Basis Of Allotment (Tentative) | Dec 26, 2024 | Dec 27, 2024 |
| Initiation of Refunds (Tentative) | Dec 27, 2024 | Dec 30, 2024 |
| Credit of Share (Tentative) | Dec 27, 2024 | Dec 30, 2024 |
| Listing date (Tentative) | Dec 30, 2024 | Dec 31, 2024 |
| Anchor Lockin End date 1 | Jan 24, 2025 | Jan 25, 2025 |
| Anchor Lockin End date 2 | Mar 25, 2025 | Mar 26, 2025 |
Senores Pharmaceuticals IPO P/E ratio is 39.77, as compared to Unimech Aerospace IPO P/E ratio of 64.37.
| Senores Pharmaceuticals IPO | Unimech Aerospace IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 66.67 | 91.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 45.77 | 79.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 39.77 | 64.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1350.70 Cr. | ₹3992.27 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.60% | 53.53% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 11.73% | 54.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.07 | 0.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.83 | ₹12.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.60% | 53.53% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Senores Pharmaceuticals IPO Retail Individual Investors (RII) are offered 14,81,272 shares while in Unimech Aerospace IPO retail investors are offered 14,81,272 shares. Qualified Institutional Buyers (QIB) are offered 44,43,818 shares in Senores Pharmaceuticals IPO and 12,70,064 shares in Unimech Aerospace IPO.
| Senores Pharmaceuticals IPO | Unimech Aerospace IPO | |
|---|---|---|
| Anchor Investor Reservation | 66,65,725 shares | 19,05,094 shares |
| Market Maker Reservation | ||
| QIB | 44,43,818 shares | 12,70,064 shares |
| NII | 22,21,908 shares | 9,52,548 shares |
| RII | 14,81,272 shares | 22,22,612 shares |
| Employee | 75,000 shares | 19,108 shares |
| Others | ||
| Total | 1,48,87,723 shares | 63,69,426 shares |
Senores Pharmaceuticals IPO subscribed 97.86x in total, whereas Unimech Aerospace IPO subscribed 184.34x.
| Senores Pharmaceuticals IPO | Unimech Aerospace IPO | |
|---|---|---|
| QIB (times) | 97.84x | 334.68x |
| NII (times) | 100.35x | 277.55x |
| Big NII (times) | 95.25x | 302.30x |
| Small NII (times) | 111.35x | 228.05x |
| RII (times) | 93.16x | 59.19x |
| Employee (times) | 100.95x | |
| Other (times) | ||
| Total (times) | 97.86x | 184.34x |
